de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons82058

Mollenkopf,  Hans J.
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

Grimm,  Christina
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82200

Wagner,  Ina
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

Lehrach,  Hans
Max Planck Society;

Nietfeld,  Wilfried
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82130

Rudel,  Thomas
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Jung, M., Mollenkopf, H. J., Grimm, C., Wagner, I., Albrecht, M., Waller, T., et al. (2009). MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. Journal of Cellular and Molecular Medicine, 13(9b), 3918-3928. doi:10.1111/j.1582-4934.2009.00705.x.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-000E-C114-E
Zusammenfassung
MicroRNAs are short single-stranded RNAs that are associated with gene regulation at the transcriptional and translational level. Changes in their expression were found in a variety of human cancers. Only few data are available on microRNAs in clear cell renal cell carcinoma (ccRCC). We performed genome-wide expression profiling of microRNAs using microarray analysis and quantification of specific microRNAs by TaqMan real-time RT-PCR. Matched malignant and non-malignant tissue samples from two independent sets of 12 and 72 ccRCC were profiled. The microarray-based experiments identified 13 over-expressed and 20 down-regulated microRNAs in malignant samples. Expression in ccRCC tissue samples compared with matched non-malignant samples measured by RT-PCR was increased on average by 2.7- to 23-fold for the hsa-miR-16, −452*, −224, −155 and −210, but decreased by 4.8- to 138-fold for hsa-miR-200b, −363, −429, −200c, −514 and −141. No significant associations between these differentially expressed microRNAs and the clinico-pathological factors tumour stage, tumour grade and survival rate were found. Nevertheless, malignant and non-malignant tissue could clearly be differentiated by their microRNA profile. A combination of miR-141 and miR-155 resulted in a 97% overall correct classification of samples. The presented differential microRNA pattern provides a solid basis for further validation, including functional studies.